Nu Holdings heads into its May 14 earnings release with options traders showing the most defensive positioning of the past year, even as short interest remains modest and the lending market stays wide open.
The clearest signal this week is in options. The put/call ratio has jumped to 0.72 — a full 2.5 standard deviations above its 20-day average of 0.59, and the highest reading recorded over the past 52 weeks. That is an unusually sharp pivot toward downside protection in a short window, and it stands out against a backdrop where short sellers have been steady rather than aggressive.
Short interest does not tell a particularly alarming story. At 3.3% of free float — roughly 128 million shares — it is low enough to be background noise rather than a structural pressure. It has drifted up about 1.4% on the week and trimmed around 2% over the past month, consistent with tentative repositioning ahead of results rather than a conviction short build. Borrowing costs have picked up about 26% on the week to 0.47%, but that is still a very cheap rate in absolute terms. Availability remains wide, with borrow easy to source, suggesting no stress in the lending market and no squeeze dynamic in play. The ORTEX short score of 34.4 — in the bottom 38th percentile of the universe — corroborates the picture: this is not a heavily shorted name.
Where the tension lies is between the Street's constructive stance and the stock's recent underperformance. The mean analyst price target of $19.87 implies roughly 39% upside from current levels at $14.25, and the analyst recommendation divergence ranks in the 92nd percentile — meaning the gap between where the stock trades and what analysts think it is worth is exceptionally wide. The most recent analyst action came from CICC, which initiated coverage with an Outperform rating and an $18 target in mid-April. Before that, UBS upgraded to Buy in March after briefly cutting its target to $17.20, signalling a quick reversal of caution. The consensus, in short, remains firmly positive. Yet the stock has given up 15% year-to-date, and the RSI of 43 reflects the subdued momentum. The P/E of 14.7x has drifted slightly lower over the past month — not dramatically cheap, but consistent with a market that has been reassessing Latin American growth names this year.
Institutional ownership offers one reassuring counterpoint. BlackRock added over 20 million shares in its most recently reported period, lifting its stake to 6.6% and making it the largest reported holder. Fidelity (FMR) added nearly 5 million shares in Q1, and T. Rowe Price built by over 4 million. Baillie Gifford, a long-standing growth-oriented holder, held steady near 5.3%. The insider picture is less clean. CEO and co-founder David Vélez sold around $660,000 worth of shares on April 23, alongside the CFO and co-founder Cristina Junqueira. Junqueira had already sold a more material $3.3 million in March. All trades carry low significance scores and likely reflect planned disposition programmes, but the directional pattern — founders selling, not buying — is worth noting ahead of a major print.
The earnings history adds context. At the last report in February, the stock fell nearly 9% on the day and lost another 9% over the five-day window — the largest single-day drop visible in the data. The prior print, in November, delivered a much gentler 2% gain on the day before giving it back over the week. Two data points do not make a pattern, but they do suggest that results-day moves here can be sharp, and that the options market's defensive tilt this week may be pricing exactly that.
The May 14 release is where this all converges — whether Nu's Q1 revenue and credit quality numbers can close the gap between the analyst consensus and the market's more cautious valuation is the question the week ahead will answer.
See the live data behind this article on ORTEX.
Open NU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
